Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
September 10, 2025Diabetes CareOpen Access

Advancing Type 1 Diabetes Management: Integrating Novel Therapies, Technologies, and Adjunctive Approaches

View Full Paper
Ask AI
Bookmark
Share

Authors

JSJennifer SnaithPNPhoom NarongkiatikhunPBPetter Bjornstad

Discussion

Loading...

Member takes

Overview

Review explores integration of adjunctive therapies and glucose monitoring in type 1 diabetes, highlighting potential benefits.

Key Points

  • Emerging therapies may reduce metabolic complications in type 1 diabetes, including vascular issues and psychological distress.
  • Novel insulin analogs and adjunctive therapies—like sodium–glucose cotransporter 2 inhibitors—aim to target unique physiological challenges.
  • Long-term management of type 1 diabetes needs to address insulin resistance and inflammatory processes beyond traditional insulin therapies.
  • Large clinical trials are essential to evaluate the effectiveness of combination therapy approaches for patient care improvement.

Cite This Study

Snaith et al. (2025) studied this question.

synapsesocial.com/papers/68c243f6b210217d647a94cchttps://doi.org/10.2337/dci25-0015
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched one closely related paper. Consider it for comparative context:

  1. 1Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes2016 · 6,909 citations